Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility
Medical Science Monitor · 20.05.2025 · 31
DOI: 10.12659/msm.947895 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Medical Science Monitor, online erschienen am 20.05.2025. Verfasst von Mehmet Kursat Derici und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey. Hauptthemen laut MEDLINE: Serum Amyloid P-Component, C-Reactive Protein, Polycystic Ovary Syndrome, Infertility, Female. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Pharmacology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Malatya Turgut Özal University, Malatya, Turkey.
Zitieren
APA
Derici, M. K., & Yıldırım, E. (2025). Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility. Medical Science Monitor, 31. https://doi.org/10.12659/msm.947895
Vancouver
Derici MK, Yıldırım E. Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility. Medical Science Monitor. 2025;31. doi:10.12659/msm.947895
BibTeX
@article{Derici2025,
author = {Derici, Mehmet Kursat and Yıldırım, Engin},
title = {Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility},
journal = {Medical Science Monitor},
year = {2025},
volume = {31},
doi = {10.12659/msm.947895}
}
EUVIMED